Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Skin sympathetic nerve activity and ventricular rate control during atrial fibrillation.

Kusayama T, Douglas A 2nd, Wan J, Doytchinova A, Wong J, Mitscher G, Straka S, Shen C, Everett TH 4th, Chen PS.

Heart Rhythm. 2019 Nov 19. pii: S1547-5271(19)31029-X. doi: 10.1016/j.hrthm.2019.11.017. [Epub ahead of print]

PMID:
31756526
2.

Skin sympathetic nerve activity and the temporal clustering of cardiac arrhythmias.

Kusayama T, Wan J, Doytchinova A, Wong J, Kabir RA, Mitscher G, Straka S, Shen C, Everett TH 4th, Chen PS.

JCI Insight. 2019 Feb 21;4(4). pii: 125853. doi: 10.1172/jci.insight.125853. eCollection 2019 Feb 21.

3.

Characteristics of synthesized right-sided chest electrocardiograms in patients with acute pulmonary embolism.

Kusayama T, Furusho H, Kinoshita M, Kaneko S, Usuda K, Takamura M.

J Cardiol. 2019 Apr;73(4):313-317. doi: 10.1016/j.jjcc.2018.12.010. Epub 2018 Dec 26.

PMID:
30594338
4.

Impact of left atrial size on isolation area in the acute phase of pulmonary vein isolation using 28 mm cryoballoon.

Chikata A, Kato T, Usuda K, Fujita S, Maruyama M, Nagata Y, Sakagami S, Kanamori N, Yaegashi T, Saeki T, Kusayama T, Usui S, Furusho H, Kaneko S, Takamura M.

Pacing Clin Electrophysiol. 2018 Jul;41(7):700-706. doi: 10.1111/pace.13337. Epub 2018 May 8.

PMID:
29603755
5.

Endogenous Selenoprotein P, a Liver-Derived Secretory Protein, Mediates Myocardial Ischemia/Reperfusion Injury in Mice.

Chadani H, Usui S, Inoue O, Kusayama T, Takashima SI, Kato T, Murai H, Furusho H, Nomura A, Misu H, Takamura T, Kaneko S, Takamura M.

Int J Mol Sci. 2018 Mar 16;19(3). pii: E878. doi: 10.3390/ijms19030878.

6.

Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal atrial fibrillation.

Kusayama T, Furusho H, Kashiwagi H, Kato T, Murai H, Usui S, Kaneko S, Takamura M.

J Cardiol. 2016 Nov;68(5):406-411. doi: 10.1016/j.jjcc.2015.11.005. Epub 2015 Dec 10.

7.

Cable externalization at the proximal portion of the superior vena cava coil in Riata implantable cardioverter defibrillator leads.

Katsuki T, Furusho H, Kusayama T, Takashima S, Kato T, Murai H, Usui S, Kaneko S, Takamura M.

J Cardiol Cases. 2016 Sep 28;15(1):3-5. doi: 10.1016/j.jccase.2016.08.009. eCollection 2017 Jan.

8.

Binding and signal transduction characteristics of the nonpeptide vasopressin V1A receptor-selective antagonist YM218 in cultured rat mesangial cells.

Tahara A, Tsukada J, Tomura Y, Kusayama T, Momose K, Taniguchi N, Suzuki T, Yatsu T, Shibasaki M.

Pharmacology. 2006;78(2):81-90. Epub 2006 Sep 11.

PMID:
16966841
9.

Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor.

Shimada Y, Taniguchi N, Matsuhisa A, Akane H, Kawano N, Suzuki T, Tobe T, Kakefuda A, Yatsu T, Tahara A, Tomura Y, Kusayama T, Wada K, Tsukada J, Orita M, Tsunoda T, Tanaka A.

Bioorg Med Chem. 2006 Mar 15;14(6):1827-37. Epub 2005 Nov 11.

PMID:
16290163
10.

Preparation of highly potent and selective non-peptide antagonists of the arginine vasopressin V1A receptor by introduction of a 2-ethyl-1H-1-imidazolyl group.

Shimada Y, Akane H, Taniguchi N, Matsuhisa A, Kawano N, Kikuchi K, Yatsu T, Tahara A, Tomura Y, Kusayama T, Wada K, Tsukada J, Tsunoda T, Tanaka A.

Chem Pharm Bull (Tokyo). 2005 Jul;53(7):764-9.

11.

Foot-use laterality in the Japanese jungle crow (Corvus macrorhynchos).

Izawa E, Kusayama T, Watanabe S.

Behav Processes. 2005 Jun 30;69(3):357-62.

PMID:
15896533
12.

Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.

Tsukada J, Tahara A, Tomura Y, Kusayama T, Wada K, Ishii N, Taniguchi N, Suzuki T, Yatsu T, Uchida W, Shibasaki M.

Vascul Pharmacol. 2005 Jan;42(2):47-55.

PMID:
15722249
13.

Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.

Tahara A, Tsukada J, Tomura Y, Kusayama T, Wada K, Ishii N, Taniguchi N, Suzuki T, Yatsu T, Uchida W, Shibasaki M.

Pharmacol Res. 2005 Mar;51(3):275-81.

PMID:
15661579
14.

Idiopathic osteonecrosis of the femoral condyle after meniscectomy.

Kusayama T.

Tokai J Exp Clin Med. 2003 Dec;28(4):145-50.

PMID:
15326876
15.

Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats.

Tahara A, Tsukada J, Tomura Y, Wada K, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

Pharmacology. 2003 Feb;67(2):106-12.

PMID:
12566855
16.

Effect of conivaptan, a combined vasopressin V(1a) and V(2) receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs.

Yatsu T, Kusayama T, Tomura Y, Arai Y, Aoki M, Tahara A, Wada K, Tsukada J.

Pharmacol Res. 2002 Nov;46(5):375-81.

PMID:
12419640
17.

Effect of YM471, a nonpeptide AVP receptor antagonist, on human coronary artery smooth muscle cells.

Tahara A, Tsukada J, Tomura Y, Wada K, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

Peptides. 2002 Oct;23(10):1809-16.

PMID:
12383869
18.

Effect of YM471, an orally active non-peptide arginine vasopressin receptor antagonist, on human vascular smooth muscle cells.

Tahara A, Tsukada J, Tomura Y, Kusayama T, Wada K, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

J Hypertens. 2002 Sep;20(9):1807-14.

PMID:
12195123
19.

Pharmacological characterization of YM471, a novel potent vasopressin V(1A) and V(2) receptor antagonist.

Tsukada J, Tahara A, Tomura Y, Wada Ki, Kusayama T, Ishii N, Aoki M, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

Eur J Pharmacol. 2002 Jun 20;446(1-3):129-38.

PMID:
12098594
20.

N-Methylbenzanilide derivatives as a novel class of selective V(1A) receptor antagonists.

Kakefuda A, Tsukada J, Kusayama T, Tahara A, Tsukamoto S.

Bioorg Med Chem Lett. 2002 Jan 21;12(2):229-32.

PMID:
11755361
21.

Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.

Tsukada J, Tahara A, Tomura Y, Wada Ki, Kusayama T, Ishii N, Yatsu T, Uchida W, Taniguchi N, Tanaka A.

Br J Pharmacol. 2001 Jul;133(5):746-54.

22.

Reinforcing effects of methamphetamine in planarians.

Kusayama T, Watanabe S.

Neuroreport. 2000 Aug 3;11(11):2511-3.

PMID:
10943713
23.

Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.

Tahara A, Tsukada J, Tomura Y, Wada Ki, Kusayama T, Ishii N, Yatsu T, Uchida W, Tanaka A.

Br J Pharmacol. 2000 Jan;129(1):131-9.

24.

[Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist].

Yatsu T, Tomura Y, Tahara A, Wada K, Kusayama T, Tsukada J, Tanaka A, Iizumi Y, Honda K.

Nihon Yakurigaku Zasshi. 1999 Oct;114 Suppl 1:113P-117P. Japanese.

PMID:
10629866
25.

Characterization of rodent liver and kidney AVP receptors: pharmacologic evidence for species differences.

Tahara A, Tsukada J, Ishii N, Tomura Y, Wada K, Kusayama T, Yatsu T, Uchida W, Tanaka A.

Regul Pept. 1999 Oct 22;84(1-3):13-9.

PMID:
10535403
26.

Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells.

Tahara A, Tsukada J, Ishii N, Tomura Y, Wada K, Kusayama T, Yatsu T, Uchida W, Tanaka A.

Eur J Pharmacol. 1999 Jul 28;378(1):137-42.

PMID:
10478574
27.

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure.

Yatsu T, Tomura Y, Tahara A, Wada K, Kusayama T, Tsukada J, Tokioka T, Uchida W, Inagaki O, Iizumi Y, Tanaka A, Honda K.

Eur J Pharmacol. 1999 Jul 9;376(3):239-46.

PMID:
10448882
28.

Characterization of vasopressin receptor in rat lung.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Neuropeptides. 1998 Jun;32(3):281-6.

PMID:
10189064
29.

Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells.

Tahara A, Saito M, Tsukada J, Ishii N, Tomura Y, Wada K, Kusayama T, Yatsu T, Uchida W, Tanaka A.

Eur J Pharmacol. 1999 Feb 26;368(1):89-94.

PMID:
10096773
30.

AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V1A or V1B receptors.

Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Pflugers Arch. 1999 Jan;437(2):219-26.

PMID:
9929562
31.

Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells.

Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Br J Pharmacol. 1998 Dec;125(7):1463-70.

32.

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Cardiovasc Res. 1998 Apr;38(1):198-205.

PMID:
9683922
33.

Binding characteristics of YM087, an AVP receptor antagonist, in rhesus monkey liver and kidney membranes.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Peptides. 1998;19(4):691-6.

PMID:
9622024
34.

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.

Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9.

PMID:
9459574
35.

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced hyperplasia and hypertrophy of cultured vascular smooth-muscle cells.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

J Cardiovasc Pharmacol. 1997 Dec;30(6):759-66.

PMID:
9436815
36.

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.

Shibasaki M, Fujimori A, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.

Eur J Pharmacol. 1997 Sep 24;335(2-3):175-84.

PMID:
9369371
37.

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.

Shibasaki M, Fujimori A, Takanashi M, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.

Eur J Pharmacol. 1997 Sep 24;335(2-3):167-73.

PMID:
9369370
38.

Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo.

Tahara A, Tomura Y, Wada KI, Kusayama T, Tsukada J, Takanashi M, Yatsu T, Uchida W, Tanaka A.

J Pharmacol Exp Ther. 1997 Jul;282(1):301-8.

PMID:
9223568
39.

Flow dependence of nitric oxide-mediated pressure change in rat mesenteric beds with different tonus.

Kusayama T, Yamazaki J, Nagao T.

Eur J Pharmacol. 1996 Oct 3;312(3):301-7.

PMID:
8894612
40.

The human posterior cruciate ligament complex: an interdisciplinary study. Ligament morphology and biomechanical evaluation.

Harner CD, Xerogeanes JW, Livesay GA, Carlin GJ, Smith BA, Kusayama T, Kashiwaguchi S, Woo SL.

Am J Sports Med. 1995 Nov-Dec;23(6):736-45.

PMID:
8600743
41.

Reconstruction of rabbit anterior cruciate ligament using the autogenous patellar tendon.

Kusayama T.

Tokai J Exp Clin Med. 1994 Sep;19(1-2):23-8.

PMID:
7660380
42.

Binding of a catechol derivative of denopamine (T-0509) and N-tert-butylnoradrenaline (Colterol) to beta 1- and beta 2-adrenoceptors.

Kusayama T, Oka J, Yabana H, Adachi-Akahane S, Nagao T.

Biol Pharm Bull. 1994 Aug;17(8):1023-7.

PMID:
7820101
43.

Anatomical and biomechanical characteristics of human meniscofemoral ligaments.

Kusayama T, Harner CD, Carlin GJ, Xerogeanes JW, Smith BA.

Knee Surg Sports Traumatol Arthrosc. 1994;2(4):234-7.

PMID:
8536047
44.

[Study on reconstruction of the anterior cruciate ligament in the monkey knee using polyester artificial ligament].

Kusayama T, Tomatsu T, Imai N.

Nihon Seikeigeka Gakkai Zasshi. 1991 Nov;65(11):1099-111. Japanese.

PMID:
1761910
45.

Autogenous meniscus grafts in articular cartilage defects--an experimental study.

Kusayama T, Tomatsu T, Akasaka O, Imai N.

Tokai J Exp Clin Med. 1991 Jul;16(2):145-51.

PMID:
1780915
46.

[Experimental studies of the osteochondral allograft].

Kusayama T.

Nihon Seikeigeka Gakkai Zasshi. 1986 Mar;60(3):349-59. Japanese.

PMID:
3722976

Supplemental Content

Loading ...
Support Center